Skip to main content
. 2023 Jun 14;12(12):4045. doi: 10.3390/jcm12124045

Table 1.

Preoperative characteristics.

UNMATCHED MATCHED
SuRD-AVR (n = 636) TAVI (n = 670) p-Value SuRD-AVR (n = 346) TAVI (n = 346) p-Value
Age (years), median (IQR) 78 (74–81) 81 (77–84) <0.001 79 (76–83) 80 (76–84) 0.266
Gender (female) 364 (57.2%) 312 (46.6%) <0.001 186 (53.8%) 189 (54.6%) 0.819
Body mass index (kg/m2) 27.1 ± 4.6 27.2 ± 4.3 0.642 26.9 ± 4.7 27.2 ± 4.9 0.069
Body surface area (m2), median (IQR) 1.81 ± 0.2 1.82 ± 0.2 0.773 1.81 ± 0.2 1.81 ± 0.2 0.923
EuroSCORE II (%), median (IQR) 2.0 (1.4–2.8) 3.0 (2.3–3.5) <0.001 2.6 (1.9–3.2) 2.5 (2.0–3.1) 0.977
Hypertension(mmHg) 532 (83.6%) 566 (84.5%) 0.682 282 (81.5%) 291 (84.1%) 0.365
Dyslipidaemia 428 (67.3%) 359 (53.6%) <0.001 196 (56.6%) 195 (56.4%) 0.939
Diabetes Mellitus 208 (32.7%) 141 (21.0%) <0.001 92 (26.6%) 83 (24.0%) 0.431
Advance NYHA (class III–IV) 253 (39.8%) 257 (38.4%) 0.598 79 (22.8%) 82 (23.7%) 0.787
COPD (FEV1 < 60%) 69 (10.8%) 93 (13.9%) 0.097 46 (13.3%) 49 (14.2%) 0.740
Previous CVA 50 (7.9%) 45 (6.7%) 0.426 21 (6.1%) 16 (4.6%) 0.398
Atrial fibrillation 63 (9.9%) 63 (9.4%) 0.758 36 (10.4%) 30 (8.7%) 0.437
Pulmonary hypertension (>30 mmHg) 179 (28.1%) 228 (34%) 0.022 114 (32.9%) 112 (32.4%) 0.871
Peripherical arterial disease 68 (10.7%) 67 (10%) 0.681 35 (10.1%) 31 (9.0%) 0.604
Previous Cardiac Surgery 12 (1.9%) 152 (22.7%) <0.001 12 (3.5%) 17 (4.9%) 0.343
Frailty 19 (2.9%) 33 (4.9%) 0.073 10 (2.8%) 15 (4.3%) 0.308
Creatinine (mg/dL), mean ± SD 0.95 ± 0.5 1.15 ± 0.6 <0.001 1.01 ± 0.7 1.06 ± 0.6 0.324
Sievers Type 1 Bicupid valve 44 (6.7%) 7 (1%) <0.001 6 (1.7%) 5 (1.4%) 0.761
SAA 111 (17.4%) 139 (20.7%) 0.130 67 (19.3%) 86 (24.8%) 0.081
Left ventricular ejection fraction, mean ± SD 57.7 ± 6 57.7 ± 7 0.478 57.6 ± 6 56.4 ± 7 0.231

NYHA: New York Heart Association; COPD: Chronic Obstructive Pulmonary Disease; SAA: Small Aortic Annulus.